"Validation of the TASQ in Patients Undergoing SAVR or TF-TAVI"

CompletedOBSERVATIONAL
Enrollment

272

Participants

Timeline

Start Date

September 8, 2017

Primary Completion Date

August 15, 2019

Study Completion Date

January 13, 2020

Conditions
Aortic Valve Stenosis
Interventions
PROCEDURE

TAVI

transfemoral transcatheter aortic valve implantation

PROCEDURE

SAVR

isolated surgical valve replacement

OTHER

MM

management of aortic stenosis by medical treatment only

Trial Locations (10)

15006

Hospital Juan Canalejo Coruna, A Coruña

24105

UKSH University Clinical Center Schleswig-Holstein, Kiel

37126

Department of Medicine, University of Verona, Verona

50134

Structual Interventional Cardiology, University Hospital Careggi, Florence

75018

Bichat Hospital - Claude-Bernard, Paris

91300

Hospital Jacques Cartier, Massy

A-6020

Medical University of Innsbruck, Innsbruck

ON 5MG 2C4

University Health Network, Toronto General Hospital, Toronto

08035

University Hospital Vall d'Hebron, Barcelona

EC1A7BE

Barts Heart Centre, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Edwards Lifesciences

INDUSTRY

lead

Institut für Pharmakologie und Präventive Medizin

NETWORK